CN103781484A - 治疗疼痛的方法 - Google Patents

治疗疼痛的方法 Download PDF

Info

Publication number
CN103781484A
CN103781484A CN201280042680.2A CN201280042680A CN103781484A CN 103781484 A CN103781484 A CN 103781484A CN 201280042680 A CN201280042680 A CN 201280042680A CN 103781484 A CN103781484 A CN 103781484A
Authority
CN
China
Prior art keywords
diclofenac
patients
pain
hpβcd
study
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201280042680.2A
Other languages
English (en)
Chinese (zh)
Inventor
P·拉库图尔
M·加西亚德罗查
D·B·卡尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hospira Inc
Original Assignee
Hospira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospira Inc filed Critical Hospira Inc
Publication of CN103781484A publication Critical patent/CN103781484A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201280042680.2A 2011-07-20 2012-07-19 治疗疼痛的方法 Pending CN103781484A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161509886P 2011-07-20 2011-07-20
US61/509,886 2011-07-20
PCT/US2012/047453 WO2013013076A1 (en) 2011-07-20 2012-07-19 Methods of treating pain

Publications (1)

Publication Number Publication Date
CN103781484A true CN103781484A (zh) 2014-05-07

Family

ID=47558482

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280042680.2A Pending CN103781484A (zh) 2011-07-20 2012-07-19 治疗疼痛的方法

Country Status (16)

Country Link
US (1) US20140221490A1 (OSRAM)
EP (2) EP2734212B1 (OSRAM)
JP (2) JP6320917B2 (OSRAM)
KR (1) KR20140063583A (OSRAM)
CN (1) CN103781484A (OSRAM)
AU (1) AU2012283915B2 (OSRAM)
BR (1) BR112014001335A2 (OSRAM)
CA (1) CA2841964A1 (OSRAM)
DK (1) DK2734212T3 (OSRAM)
ES (1) ES2646226T3 (OSRAM)
IL (1) IL230433A0 (OSRAM)
IN (1) IN2014CN00315A (OSRAM)
MX (1) MX350463B (OSRAM)
MY (1) MY166036A (OSRAM)
NO (1) NO2854815T3 (OSRAM)
WO (1) WO2013013076A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160033796A (ko) * 2006-03-28 2016-03-28 자블린 파머슈티칼스 인코포레이티드 저 복용량의 디클로페낙 및 베타-사이클로덱스트린 제형
DK2158316T3 (en) 2007-05-11 2015-07-20 Adynxx Inc Gene expression and pain
EP3456707B1 (en) 2007-11-06 2020-04-15 PTC Therapeutics, Inc. 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
RU2668136C2 (ru) 2012-05-10 2018-09-26 Эйдинкс, Инк. Композиции для доставки активных ингредиентов
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
JP6705807B2 (ja) 2014-08-15 2020-06-03 エーダイニクス インコーポレイテッド 疼痛を治療するためのオリゴヌクレオチドデコイ
US20200017853A1 (en) * 2016-02-29 2020-01-16 Adynxx, Inc. Compositions and methods for pain amelioration via modification of gene expression
US20180025116A1 (en) * 2016-07-22 2018-01-25 Arizona Board Of Regents On Behalf Of University Of Arizona Clinical Event Management and Communication System
JP6633777B2 (ja) 2017-08-24 2020-01-22 ノヴォ ノルディスク アー／エス Ｇｌｐ−１組成物及びその使用
US20200027555A1 (en) * 2018-07-17 2020-01-23 Lewis Pharmaceutical Information, Inc. Patient centric drug analysis platform
AU2021208601B2 (en) * 2020-02-18 2025-06-05 Novo Nordisk A/S Glp-1 compositions and uses thereof
CN111494446B (zh) * 2020-05-18 2021-08-17 深圳市宝安中医院（集团） 治疗胆绞痛的中药组合物及其应用
KR20240054306A (ko) * 2021-08-31 2024-04-25 에티스모스 리서치, 인코포레이티드 통증 및 연관 증상을 예방하고 치료하는 방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070232566A1 (en) * 2006-03-28 2007-10-04 Curtis Wright Formulations Of Low Dose Diclofenac And Beta-Cyclodextrin
US20090292022A1 (en) * 2008-05-23 2009-11-26 Aaipharma Inc. Method of Treating Post-Surgical Acute Pain

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8506792D0 (en) 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US6407079B1 (en) 1985-07-03 2002-06-18 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5389681A (en) 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA949182B (en) 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
US6828299B2 (en) 2000-06-22 2004-12-07 Theravance, Inc. Polyhydroxy glycopeptide derivatives
WO2003059393A1 (en) 2002-01-15 2003-07-24 Altana Pharma Ag Pantoprazole cyclodextrin inclusion complexes
US6869939B2 (en) 2002-05-04 2005-03-22 Cydex, Inc. Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
JP2007521206A (ja) * 2003-11-04 2007-08-02 オーチス　エレベータ　カンパニー 乗客用コンベヤの自動低速運転
SI1574221T1 (sl) 2004-03-10 2007-10-31 Shimoda Biotech Pty Ltd Stabilni sestavki diklofenaka za vbrizgavanje
KR20090010953A (ko) * 2006-03-28 2009-01-30 자블린 파머슈티칼스 인코포레이티드 저 복용량의 비-스테로이드성 항염증성 약물 및 베타-사이클로덱스트린 제형
CN101264086A (zh) 2007-03-14 2008-09-17 南京师范大学 含有头孢克肟环糊精包合物的药物组合物及其制备方法
WO2009089269A1 (en) * 2008-01-07 2009-07-16 Javelin Pharmaceuticals, Inc. Methods of treating pain while minimizing adverse effects on platelet function

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070232566A1 (en) * 2006-03-28 2007-10-04 Curtis Wright Formulations Of Low Dose Diclofenac And Beta-Cyclodextrin
US20090292022A1 (en) * 2008-05-23 2009-11-26 Aaipharma Inc. Method of Treating Post-Surgical Acute Pain

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AMMON ET AL: "《diclofenac does not interact with codeine metabolism in vivo:a study of healthy volunteers》", 《BMC CLINICAL PHARMACOLOGY》 *
CHRISTENSEN ET AL: "《a double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain》", 《ANESTH. PROG.》 *

Also Published As

Publication number Publication date
MX350463B (es) 2017-09-06
MY166036A (en) 2018-05-21
JP2017110022A (ja) 2017-06-22
EP2734212A1 (en) 2014-05-28
US20140221490A1 (en) 2014-08-07
NO2854815T3 (OSRAM) 2018-04-21
JP2014520893A (ja) 2014-08-25
JP6320917B2 (ja) 2018-05-09
IN2014CN00315A (OSRAM) 2015-04-03
CA2841964A1 (en) 2013-01-24
BR112014001335A2 (pt) 2017-02-21
IL230433A0 (en) 2014-03-31
DK2734212T3 (da) 2017-11-06
EP3257505A1 (en) 2017-12-20
ES2646226T3 (es) 2017-12-12
EP2734212B1 (en) 2017-09-06
KR20140063583A (ko) 2014-05-27
MX2014000744A (es) 2014-05-14
AU2012283915A1 (en) 2014-02-06
AU2012283915B2 (en) 2016-11-24
EP2734212A4 (en) 2014-12-24
WO2013013076A1 (en) 2013-01-24

Similar Documents

Publication Publication Date Title
CN103781484A (zh) 治疗疼痛的方法
JP7487264B2 (ja) ５－コレステン－３，２５－ジオール，３－サルフェート（２５ｈｃ３ｓ）又は薬学的に許容される塩及び少なくとも１種の環状オリゴ糖を含む組成物
AU2017245341B2 (en) Treatment of degenerative joint disease
Simon et al. The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran
Marino et al. Management of dabigatran‐associated bleeding with two doses of idarucizumab plus hemodialysis
CN103957886B (zh) 稳定的抗炎注射溶液剂
Miller et al. Plasma ropivacaine concentrations following local infiltration analgesia in total knee arthroplasty: a pharmacokinetic study to determine safety following fixed-dose administration
CA3040628A1 (en) Treatment regimens
HK1197651A (en) Methods of treating pain
HK1194676B (en) Compositions comprising diclofenac for the treatment of post-operative pain
HK1194676A (en) Compositions comprising diclofenac for the treatment of post-operative pain
Beaudoin et al. Effect of losartan on uric acid metabolism in children with proteinuric kidney disease: crossover randomized controlled clinical trial
WO2011027246A1 (en) A cream comprising miconazole nitrate and a biopolymer for the treatment of diaper rash
Pili-Floury et al. Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy
HK40084620A (en) Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
Hull et al. A randomized trial of the effect of low molecular weight heparin vs. warfarin on mortality in the long-term treatment of proximal vein thrombosis
Camsari Aykut Sifil, Cem Mermut, Yavuz Yenicerioglu, Caner Cavdar, Mukaddes Gumustekin, 2 Ali Celik, Faize Yuksel, 3

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1197651

Country of ref document: HK

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20140507

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1197651

Country of ref document: HK